Scinai Immunotherapeutics Highlights Expanded CDMO Platform and Immunology Pipeline at BIO-Europe Spring® 2026
Scinai Immunotherapeutics Ltd. - American Depositary Shares (SCNI)
Company Research
Source: PR Newswire
JERUSALEM, March 19, 2026 /PRNewswire/ -- Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI), a biopharmaceutical company advancing a pipeline of innovative inflammation and immunology therapeutics, and the owner of Scinai Biopharma Services Ltd., a rapidly expanding contract development and manufacturing organization (CDMO) serving biotechnology and pharmaceutical companies, today announced its participation in BIO-Europe Spring® 2026, taking place March 23–25 in Lisbon, Portugal.This will be Scinai's first major international conference following its recent acquisition of Recipharm Israel and strategic collaboration with Recipharm, marking a significant expansion of its development and manufacturing capabilities.The Scinai delegation will include:Amir Reichman, Chief Executive Officer, representing Scinai Immunotherapeutics' R&D activitiesSolomon Gahtan, Business Development & Alliance Management, BiologicsDr. Helen Domeshek, Business Development & Alliance Management, Small MoleculesMr.
Show less
Read more
Impact Snapshot
Event Time:
SCNI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SCNI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SCNI alerts
High impacting Scinai Immunotherapeutics Ltd. - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
SCNI
News
- Scinai Immunotherapeutics Receives Nasdaq Notification Regarding Minimum Bid Price [Yahoo! Finance]Yahoo! Finance
- Scinai Immunotherapeutics Receives Nasdaq Notification Regarding Minimum Bid PricePR Newswire
- Scinai Signs Second Amendment to PinCell Option Agreement and Submits Revised €12 Million Non-Dilutive FENG Application to Advance PC111 Through Human Proof of ConceptPR Newswire
- Scinai Announces Expanded Israel Innovation Authority Support for Robotic Aseptic Fill & Finish Platform [Yahoo! Finance]Yahoo! Finance
- Scinai Announces Expanded Israel Innovation Authority Support for Robotic Aseptic Fill & Finish PlatformPR Newswire
SCNI
Sec Filings
- 3/19/26 - Form 6-K
- 3/18/26 - Form 3
- 3/18/26 - Form 3
- SCNI's page on the SEC website